Monthly Archives: March 2017

Altima Intends to Complete 15:1 Consolidation

VANCOUVER, BC / ACCESSWIRE / March 31, 2017 / Altima Resources Ltd. (TSXV: ARH) (FSE: AKC) (OTC PINK: ARSLF) (the Company or Altima) announces that it intends to consolidate its share capital on an 15 old shares for 1 new share basis, subject to receipt of acceptance from the TSX Venture Exchange (“TSX-V”). Shareholders approved the proposed 15:1 consolidation by Special Resolution at the Company’s Annual General and Special Meeting that was held on December 12, 2016. The Company does not intend to change its name in connection with the consolidation.

Management anticipates that a consolidation will assist the Company by attracting a broader shareholder audience, ultimately enabling the Company to more readily obtain future equity financings to continue its growth through drilling and exploration.

The Company will disseminate a further News Release upon receipt of acceptance from the TSX-V, which will set out the Effective Date for the consolidation.

ON BEHALF OF THE BOARD

SIGNED: “Joe DeVries”
Joe DeVries, President and CEO

Contact:

Joe DeVries
(604) 336-8610

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Altima Resources Ltd.

ReleaseID: 458707

EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Babcock & Wilcox Enterprises, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / March 31, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Babcock & Wilcox Enterprises, Inc. (“Babcock” or the “Company”) (NYSE: BW). Investors, who purchased or otherwise acquired shares between July 1, 2015 and February 28, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 2, 2017 lead plaintiff motion deadline.

If you purchased shares of Babcock during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint alleges that throughout the Class Period, Babcock issued materially false and/or misleading statements and/or failed to disclose issues with the Company’s European renewable contract, including the issues it caused with productivity and schedule issues in other Renewable segment projects; and the effect these issues would have on the Company’s financials and the Company’s ability to meet its guidance. On February 28, 2017, Babcock disclosed disappointing fourth quarter 2016 results that were below analyst expectations, citing strong declines in its Renewable Energy segment. The Company reported “fourth quarter 2016 revenues of $380.0 million, a decrease of $122.7 million, or 24.4%, compared to the fourth quarter of 2015.” The Company also reported a GAAP loss per share of $1.47 for the fourth quarter of 2016, compared to a loss per share of $0.10 for the fourth quarter of 2015. When this information reached the investing public, shares of Babcock decreased in value.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458704

IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / March 31, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against SCYNEXIS, Inc. (“SCYNEXIS” or the “Company”) (Nasdaq: SCYX). Investors who purchased shares (1) pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company’s Initial Public Offering on or about May 2, 2014 and/or (2) between May 2, 2014 and March 2, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 8, 2017 lead plaintiff motion deadline.

If you purchased shares of SCYNEXIS during the IPO or Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, SCYNEXIS made false and/or misleading statements and/or failed to disclose: that the Company’s lead product, SCY-078, posed substantial undisclosed health and safety risks; that SCYNEXIS overstated the drug’s approval prospects and/or commercial viability; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On March 2, 2017, SCYNEXIS announced that the U.S. Food and Drug Administration “informed the Company to hold the initiation of any new clinical studies with the intravenous (IV) formulation of SCY-078 until the FDA completes a review of all available pre-clinical and clinical data” of the formulation. The hold stems from “three mild-to-moderate thrombotic events in healthy volunteers” receiving the formulation. When this news was announced to the public, shares of SCYNEXIS fell in value.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458705

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Rentech, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Rentech, Inc. (“Rentech” or the “Company”) (NASDAQ: RTK) concerning possible violations of federal securities laws between November 9, 2016 and February 20, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the April 24, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that during the Class Period, Rentech made false and/or misleading statements and/or failed to disclose that: the Company’s resources were not sufficient to overcome any operating challenges and remaining bottleneck at its Wawa facility; that the Wawa facility would not reach approximately 60% of production capacity within the next couple quarters and achieve full capacity in the range of 400,000 to 450,000 metric tons late in the year; and that as a result of the above, Rentech’s statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. On February 21, 2017, Rentech announced its decision to idle the Wawa facility due to equipment and operational issues that would require additional capital investment. When this news was announced, shares of Rentech fell in value, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 458702

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Northern Dynasty Minerals Ltd. and Encourages Investors with Losses Over $100,000 to Contact the Firm

IRVINE, CA / ACCESSWIRE / March 31, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Northern Dynasty Minerals Ltd. (“Northern Dynasty” or the “Company”) (NYSE MKT: NAK). Investors who purchased or otherwise acquired shares between September 16, 2013 and February 13, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the April 17, 2017 lead plaintiff motion deadline.

If you purchased shares of Northern Dynasty during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, Northern Dynasty issued materially false and/or misleading statements and/or failed to disclose: that the Pebble Project carries a negative net present value; that the Pebble Project is not commercially viable; and that as a result of the above, the Company’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. On February 14, 2017, Seeking Alpha published an article alleging that “Northern Dynasty is worthless” because its Pebble Project is not “commercially viable.”

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458701

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Global Eagle Entertainment Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / March 31, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Global Eagle Entertainment Inc. (“Global Eagle” or the “Company”) (NASDAQ: ENT). Investors, who purchased or otherwise acquired shares between July 27, 2016 and February 17, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the April 24, 2017 lead plaintiff motion deadline.

If you purchased shares of Global Eagle during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint alleges that the Company made false and/or misleading statements and/or failed to disclose that: Global Eagle was unable to timely and properly account for its acquisition of Emergency Markets Communications (“EMC”); that the Company lacked effective internal controls over financial reporting; and that as a result of the above, Global Eagle’s financial statements were materially false and misleading at all relevant times. On February 21, 2017, pre-market, Global Eagle announced that its CEO, David M. Davis, and its CFO, Thomas E. Severson Jr., resigned from their positions with the Company. Global Eagle also announced that it expected to file its Annual Report for fiscal year 2016 after the March 16, 2017 U.S. Securities and Exchange Commission deadline, citing the Company’s “increased size and complexity” after its acquisition of EMC, as well as “its need to transition the finance department after the prior CFO’s departure and its need to complete additional financial-closing procedures associated with the Company’s material weaknesses in internal control over its financial reporting.” When this news was announced, shares of Global Eagle fell in value.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458700

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against USANA Health Sciences, Inc. (“USANA” or the “Company”) (NYSE: USNA) concerning possible violations of federal securities laws between March 14, 2014 and February 7, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the April 14, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, USANA made materially false and/or misleading statements and/or failed to disclose that: the Company’s BabyCare Ltd. subsidiary engaged in improper reimbursement practices in China; that these practices constituted violations of the Foreign Corrupt Practices Act; that the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; that the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and that as a result of the above, USANA’s public statements were materially false and misleading at all relevant times.

On February 7, 2017, USANA announced that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act…and certain conduct and policies at BabyCare, including BabyCare’s expense reimbursement policies.” When this information was released to the public, shares of USANA fell in value, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 458699

Wamco Technology Group Ltd. Enters into Binding Agreement with TCG Acquisition Corp. to Complete Reverse Take-over

TORONTO, ON / ACCESSWIRE / March 31, 2017 / Wamco Technology Group Ltd. (the “Company” or “Wamco”) is pleased to announce that it and certain of its principal shareholders have entered into a binding agreement (the “Agreement”) with TCG Acquisition Corp. (“TCG”) which outlines the general terms and conditions of a proposed transaction pursuant to which Wamco will acquire all of the issued and outstanding securities of TCG in exchange for securities of Wamco. The proposed transaction is anticipated to be carried out by way of amalgamation or other similar transaction, pursuant to which TCG will amalgamate with a wholly-owned subsidiary of Wamco (the “Proposed Transaction”). As a result of the Proposed Transaction, the Company will continue on with the business of TCG.

Wamco is a reporting issuer in the Provinces of Alberta and British Columbia and its common shares (the “Wamco Shares”) are not currently listed on any exchange or market. As contemplated by the Agreement, Wamco and TCG intend to apply to the Canadian Stock Exchange (“CSE”) for the listing of the Wamco Shares (the “Listing”). Wamco has no commercial operations, no assets and minimal liabilities.

TCG is a privately held company incorporated pursuant to the Business Corporations Act (Ontario). TCG has been formed for the initial purpose of making investments primarily in the United States.

The Proposed Transaction is subject to, among other things, receipt of the requisite shareholder approvals, approval of the CSE, and additional conditions as described in the Agreement. Holders of greater than 70% of the Wamco Shares have entered into agreements to support the Proposed Transaction.

Prior to the completion of the Proposed Transaction, Wamco will call a meeting of its shareholders for the purpose of approving, among other matters, (i) a possible consolidation of the issued and outstanding Wamco Shares (the “Consolidation”); (ii) a change of name of Wamco to a name to be determined by TCG and acceptable to regulatory authorities; (iii) the election of nominees of TCG to the board of directors of Wamco; (iv) the approval of the Proposed Transaction, if required under applicable law; and (v) such other matters as the parties or the CSE may require. Upon closing of the Proposed Transaction, the board of directors of Wamco will be reconstituted in a manner that complies with the requirements of the CSE and applicable securities laws. TCG shall be entitled to all nominees on the reconstituted board, subject to the receipt of applicable regulatory approvals.

In connection with the Proposed Transaction, TCG intends to undertake one or more equity financings (the “TCG Financing”). Further information regarding such financing(s) will be available in due course. Upon closing of the Proposed Transaction, all securities of TCG issued in connection with the TCG Financing will automatically be exchanged for post-Consolidation Wamco Shares on the same terms as existing TCG securities.

Further details about the Proposed Transaction and the resulting issuer will be provided in a comprehensive news release and in the disclosure document to be prepared and filed in respect of the Proposed Transaction. Wamco and TCG intend that the Agreement will be superseded by a definitive amalgamation agreement which will be filed on the Company’s SEDAR profile at www.sedar.com.

Investors are cautioned that, except as disclosed in the disclosure document to be prepared in connection with the Proposed Transaction, any information released or received with respect to the Proposed Transaction may not be accurate or complete and should not be relied upon.

For further information please contact:

Wamco Technology Group Ltd.
Lisa McCormack
President
Email: lmccormack@irwinlowy.com

or

TCG Acquisition Corp.
Richard A. Kimball, Jr.
Chief Executive Officer
Email: Richard.kimball@costeragroup.com

The CSE has in no way passed upon the merits of the Proposed Transaction or the listing of the Wamco Shares, and has neither approved nor disapproved the contents of this news release. Approval of the CSE for the listing of the Wamco shares will be subject to, among other things, the resulting issuer satisfying the listing requirements of the CSE. There can be no assurance that the approval of the CSE regarding the listing of the Wamco shares will be obtained.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

All information contained in this news release with respect to Wamco and TCG was supplied by the parties, respectively, for inclusion herein, and Wamco and its directors and officers have relied on TCG for any information concerning such party.

Forward-Looking Information

This news release contains forward-looking information based on current expectations. Statements about, among other things, the closing of the Proposed Transaction, expected terms of the Proposed Transaction, the number of securities of Wamco that may be issued in connection with the Proposed Transaction, the ownership ratio of the resulting issuer post-closing, the TCG Financing, the Consolidation, shareholder approval and the parties’ ability to satisfy closing conditions and receive necessary approvals are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the Proposed Transaction will occur or that, if the Proposed Transaction does occur, it will be completed on the terms described above. Wamco and TCG assume no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

SOURCE: Wamco Technology Group Ltd.

ReleaseID: 458703

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against HMS Holdings Corp. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against HMS Holdings Corp. (“HMS” or the “Company”) (Nasdaq: HMSY) concerning possible violations of federal securities laws between May 10, 2016 and March 2, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired HMS shares during the Class Period should contact the firm prior to the May 2, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, during the Class Period, HMS made false and/or misleading statements and/or failed to disclose that the Company lacked effective internal control over financial reporting and as a result, its financial statements were materially false and misleading at all relevant times. On March 2, 2017, HMS announced it would delay filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2016. The Company stated it needed additional time in order to “complete documentation related to the Company’s previously disclosed review of its CMS reserves and related internal controls over financial reporting. In this regard, the Company’s auditor has informed the Company that it has identified what it believes is a material weakness in the Company’s internal controls over financial reporting related to the CMS reserves.” When this news was revealed, shares of HMS fell in value, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 458698

IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against NantHealth, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / March 31, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq: NH). Investors who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 8, 2017 lead plaintiff motion deadline.

If you purchased shares of NantHealth during the IPO or Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint states that during the Class Period, NantHealth made materially false and/or misleading statements and/or failed to disclose: that its founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; that NantHealth and Soon-Shiong violated federal tax laws; that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and that the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016. When this information reached the public, shares of NantHealth decreased in value, thus harming investors.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458696